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1060-63 Identification of Regional Differences in 
Proinflammatory Cytokine Concentrations in Chronic 
Heart Failure due to Chagas Cardiomyopathy: A Key 
Element in the Comprehension of the Disease 
Fabio Vilas-Boaa Ricardo Ribelm dos Santos, Milena B.P. Soares, Joel A. Pinho Filho, 
Ana Gabriela C. Silva. Adrian0 D. Oliveira. Antonio M. Azevedo. Jr.. Fernando Bullos 
Filho. Gilson S. Feltosa, Edimar A. Bocchi, Hospital Santa Izabel, Salvador-BA, Brazil. 
Heart Institute Umversity of Sao Paula Medical School, Sao Paula, Brazil 
Background: Despite the existing evidence suggesting an important role of cytokines in 
the development of heart failure (HF), the origin of its production remains unclear: it may 
be produced by the heart or by extramyocardial sites. The purpose of this study is to 
investigate If the serum concentrations of proinflammatory cytokines in patients with HF 
due to Chagas’ Cardiomyopathy (CC) are higher than in normal controls and If there are 
regional differences in the concentrations of cytoklnes. 
Methods: The population studied consisted of patients with heart failure due to CC 
[n=22, age 52+9 y; 17 male, left ventricular ejection fraction (EF) 20.7*6.6%; B-type 
natriuretlc peptide (BNP) 514+431 pg/ml] and normal individuals (n=9; age 53+7 y; 6 
male; EF 63*4; BNP 10.7+6 pg/ml), submitted to right and left heart catheterization. 
Blood samples were drawn from the aorta, coronary sinus and supra-hepatic vein. 
Serum cytoki,nes were measured by the ELISA sandwich technique; Nitric oxide (NO) 
was analyzed by the Griess method; BNP was analyzed by ELISA (Biosita); patients 
were also submitted to 2-D echocardiogram, 6-min walking test and quality of live ques- 
tionnaire (Minnesota). 
Results: Serum concentrations of TNF-alfa and gamma-interferon were significantly 
higher in patients than in controls (133.8+21.3 Versus 4.3+2.1 p<O.OOl; 367*93 Versus 
26+8 qO.001); in patients, TNF-alfa was higher in coronary sinus (262.8+55.3) than in 
aorta (133.8r21.3: pr0.001) and supra-hepatic vein (185.2+36.8; ~~0.05); TGF-beta 
didn’t differ from controls (119k3.6 versus 115+8.3; p=NS); NO was undetectable. Con- 
gestive states, evaluated by hemodynamic measures, correlated with TNF-alfa (wedge 
pressure: R&63; p=O.O03; right atrial pressure: Rc0.70; p<O.OOl). BNP levels (R=0.58; 
p=O.O4) and serum sodium (R= -0.54; p=O.O38) also correlated with TNF-alfa levels. 
Conclusions: For the first time, a transmyocardial cytokine gradient was demonstrated 
in patients with HF. This evidence suggests that the heart is the main site of relative pro- 
duction of cytoklnes in patients with HF and contributes for a better understanding of the 
immune activation process in patients with HF due to CC. 
1060-64 Nitric Oxide Regulation of Myocardial Contractility and 
Calcium Cycling: Independent Impact of Neuronal and 
Endothelial Nitric Oxide Synthases 
Shakil A. Khan, Michel W. Skaf, Kwangho Lee, Robert W. Harnson, Micheal Fradley, 
Artin A. Shoukas. Dan E. Berkowitz. Joshua M. Hare. Johns Hooklns Medical 
Institutions. Baltimore, MD 
Background: Depression of beta-adrenergic and frequency-related myocardial contrac- 
tion is characteristic of heart failure. The role nitric oxide plays I” the contractile depres- 
sion of heart failure remains controversial. Nitric oxide synthases (NOS) have specific 
spatial localization on cardiac myocytes and could distinctively modulate frequency- 
dependent contraction. We tested the hypothesis that deficiency of NOSl, located on the 
sarcoplasmic reticulum (SR) where it facilitates SR calcium cycling, selectively 
depresses force frequency responses. 
Methods: We measured sarcomere shortening and calcium transients ([Caz+],) in myo- 
cytes isolated from mice lacking NOSl (NOSI +), NOS3 (NOS3”) and their wild type 
controls during escalating pacing rates (1-4 hz) at 37” C. We also studied the effects of 
transesophageal pacing (660-840 bpm) on contractility in intact mice. 
Results: Wild type myocytes exhibited increased sarcomere shortening (peak increase at 
4hz of 293+105%, PcO.001) and [C$+], (52*19%, pcO.001) with pacing. NOS3’- myo- 
cytes had similar responses (sarcomere shortening, 245*47%, PcO.001 and [Cap*], 
36%+8, p<O.Ol). In contrast, NOSl-’ myocytes had a markedly blunted response with 
sarcomere shortening increase of only 87*33% (P&O5 compared to wild type and 
NOS3.‘-) and an insignificant rise in [CaZ’], (17*1 l%, P>O.OS vs. baseline and PcO.05 
compared to wild type and NO!&). Consistent results were seen in intact mice as 
increasing pacing frequencies augmented contractlllty in wild type (peak rise in dP/dt nor- 
malized to EDV of 51+5% at 840 bpm, P.zO.01) and NOS3” (34+7%, PcO.O5), while this 
response was attenuated in NOSl -‘- (15+5% increase in dP/dt-EDV. P<O.Ol compared 
to wild type and NOS3’-). 
Conclusions: NOSl deficiency leads to Impaired frequency-dependent contractility and 
calcium cycling. These findings suggest that only NOSl, but not NOS3. facilitates fre- 
quency-related lootropic responses. Thus, selective impairment of NOSl may be of 
pathophysiologic significance in heart failure. 
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Structural Protein, Sequence, Genomic Structure, 
Tissue Distribution, and Association With 
Cardiomyopathy 
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Background: Linkage Identifies lOq24-26 as a locus for dilated cardiomyopathy (DCM), a 
region including the N-RAP gene. Murine N-RAPcDNA predicts a protein wth nebulin 
repeats and a LIM domain. In cardiomyocytes N-RAP may anchor myofibrils to interca- 
lated discs, mediating force transmw~on and myofibril assembly. In skeletal muscle, N- 
RAP is localized at myotendinous junctions, sites of force transmission. We sought to 
describe the sequence. genomic structure and expression of human N-RAPand deter- 
mine whether mutations cause DCM or hvpertroohic cardiomvooathv (HCMI. 
Methods and Results: Human expressed sequence tag (EST) databases were searched 
with the published 3528 bp mouse N-RAPopen reading frame (ORF). A putatlve cDNA 
sequence was constructed and interrogated by direct sequencing from cardiac and skel- 
etal muscle RNA. Two humanN-RAPcDNA lsoforms were identified wth ORFs of 5085 
bp (isoform C) and 5190 bp (isoform S), coding products of 193-197 kDa. Genomic data- 
base searches localize N-RAP to 10q25.3 and match isoforms C and S to 41 and 42 
axons respectively. Genomic structure was confirmed by DNA sequencing. Only isoform 
C is detected I” human cardiac RNA; in skeletal muscle -10% is lsoform C and -90% 
lsoform S. Apparent differences between human N-RAP cDNA and mouse sequences 
were investigated. Two mouse N-RAP isoforms with ORFs of 5079 and 5184 bp were 
identified with - 85% similarity to human isoforms; published mouse sequences include 
cloning artifacts truncating the ORF. Mur~ne and human isoforms have similar gene 
structure, tissue specificity, and immunoblot mobility. No N-RAP mutations were identi- 
fied in 50 DCM and HCM patients, but several polymorphisms were detected. Conclu- 
sions: (1) Genomic and cDNA sequences of mouse and human N-RAPare described. N 
RAPencodes a highly conserved protein; (2) N-RAP is exclusively expressed in cardiac 
and skeletal muscle, with tissue specific isoforms; and (3)N-RAP mutations are not corn- 
moo causes of cardiomyopathy, but remain excellent candIdate causes or modifying fac- 
tors for cardiac and skeletal myopathies. Current studies will determine the role of N-RAP 
variants in myocyte development and in myopathies. 
1060-66 Mitochondrial Membrane Potential Is Decreased in 
Failing Cardiomyocytes and Is Associated With 
Decreased Cytochrome Oxidase-Dependent 
Respiration 
Anastassia V. Todor, Victor G. Sharov, Hideaki Morita, Hani N. Sabbah, Henry Ford 
Health System, Detroit, Ml 
Background: We previously showed that mitochondnal respiration is depressed in fail- 
ing cardiomyocytes (CM). The mechanism for this maladaptation is unknown. We postu- 
late that in failing CM, loss of cytochrome c and reduction of mitochondrial membrane 
potential @+r,,,) can contribute to abnormal mitochondrlal function. In this study, we 
examined the relationship between Av~ and cytochrome oxidase dependent respiration 
(CODR) before and after the addition of cytochrome c. Methods: CM wars Isolated from 
LV myocardium of 5 dogs with coronary microembolization-induced heart failure and 5 
normal dogs. Studies were performed using saponin-skinned CM. CODR was measured 
in the presence of 1 mM ADP, 5 mM malate. 5 mM pyruvate. 5 mM succinate. 1 mM 
ascorbate and 0.4 mM TMPD before and after the addition of 10 PM cytochrome c. 
CODR was measured using a Clark electrode and quantified I” ng Q/ min/lx105 CM. 
Awm was measured as a ratio of rhodamine/FITC intensity units using BioVision Mito- 
Capture Mitcchondrial Detection Kit and a fluorometer. Results: Results are shown in 
the table. Both CODR anAWm were reduced in falling CM compared to normal CM. The 
addition of cytochrome c significantly increased CODR in failing CM and did not affect 
CODR in normal CM. Conclusions: Ah and CODR are decreased in failing CM. The 
addition of exogenous cytochrome c only partially restored CODR. The findings support 
the concept that abnormalities of mitochondrial respiration in heart failure may be due in 
part to reduced A\y, and loss of cytochrome c. 
AWm CODR without cytochrome c CODR with cyiochrome c 
Normal CM 2.3+0.21 17526.6 174+7.0 
Failing 1.6+0.04’ 116+8.2’ 147+9.0’” 
CM 
*=p<O.O5 vs. normal CM; A=pc0.05 vs. CODR without cytochrome c 
1060-67 Mechanisms Underlying the Putative Role of 
Transforming Growth Factor Beta-l in Pathological 
Collagen Deposition in Chronic Heart Failure 
Rachel Denver, Alex Tzanidis. Salvatore Pepe, Deahne Quick, Henry Krum, Monash 
University, Melbourne, Australia 
Background: We have previously demonstrated that transforming growth factor beta-l 
(TGFbl) mRNA is increased in peripheral blood mononuclear cells (PBMCs) of chronic 
heart failure (CHF) patients (pts) vs normal subjects. However, factors leading to this 
activation have not been determined. To examine this question. we explored a range of 
stimuli for TGFbl in PBMCs. In addition, given that Infiltrating MCs may release factors 
that act on resident cardiac fibroblasts to increase collagen deposition, we determined 
the effect of TGFbl on markers of fibrosls within the heart 
Methods: PBMCs from normal subjects & symptomatic CHF pts were isolated from 
venous blood by gradient centrifugatlon. Isolated cells were cultured in DMEM with 1% 
FCS and stimulated with PHA Bug/ml & LPS 2Oug/ml. ET-l or All (both at lo-7M) for up 
to 48 hrs. Unstimulated cells served as controls. Total RNA was extracted and real-time 
PCR was used to measure TGFbl mRNA. Left ventricular fibroblasts (VFs) were isolated 
from explanted human heart tissue and stimulated with various growth factors (including 
TGFbl at 60uM) at passages 4-6 for up to 48 hrs. al(I)-procollagen I mRNA was mea- 
sured and collagen production estimated by [SH]-proline incorporation. 
Results: We observed a time-dependent wxrease in TGFbl mRNA with PHAiLPS stimu- 
lation in PBMC, maximal at 48 hrs in both groups, greater in CHF patients (393+98%, 
n=4) than normal subjects (235*54%, n=4). both ~~0.05. In contrast, neither ET-1 nor All 
increased TGFbl mRNA in either group. TGFbl stimulation of VFs increased al(I)-pro- 
collagen I mRNA by 296*9% at 48 hrs (p=O.O02) and [3H]-proline Incorporation by 
333*57% at 48 hrs (p<O.OOl vs unstimulated cells, n=6). The magnitude of these effects 
was greater than the highest doses of ET-l, All and TNFa. 
Conclusions: PHAfLPS but not ET-l or All increase TGFbl mRNA in PBMCs, with cells 
